Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
1.
Nat Commun ; 8: 14209, 2017 01 23.
Article in English | MEDLINE | ID: mdl-28112205

ABSTRACT

Human T-cell function is dependent on T-cell antigen receptor (TCR) and co-signalling as evidenced by immunodeficiencies affecting TCR-dependent signalling pathways. Here, we show four human patients with EBV+ disseminated smooth muscle tumours that carry two homozygous loss-of-function mutations in the CARMIL2 (RLTPR) gene encoding the capping protein regulator and myosin 1 linker 2. These patients lack regulatory T cells without evidence of organ-specific autoimmunity, and have defective CD28 co-signalling associated with impaired T-cell activation, differentiation and function, as well as perturbed cytoskeletal organization associated with T-cell polarity and migration disorders. Human CARMIL2-deficiency is therefore an autosomal recessive primary immunodeficiency disorder associated with defective CD28-mediated TCR co-signalling and impaired cytoskeletal dynamics.


Subject(s)
Immunologic Deficiency Syndromes/genetics , Microfilament Proteins/metabolism , CD28 Antigens/genetics , CD28 Antigens/metabolism , Child , Child, Preschool , Genotype , Homozygote , Humans , Microfilament Proteins/genetics , Mutation , Signal Transduction
2.
Vet Pathol ; 48(6): 1118-24, 2011 Nov.
Article in English | MEDLINE | ID: mdl-20861497

ABSTRACT

Inflammatory changes associated with periarticular pure gold bead implants were studied in dogs involved in a clinical trial investigating motor dysfunction and chronic pain owing to hip joint dysplasia and osteoarthritis. Gold beads were percutaneously implanted via a needle into different locations surrounding the greater trochanter of the femur. Nine dogs with implants were necropsied. In all examined animals, characteristic histologic lesions were observed in the tissue surrounding the gold implants--namely, a fibrous capsule composed of concentric fibroblasts intermixed with a variable number of inflammatory cells and a paucicellular innermost layer of collagen with a few fibrocyte-like cells in empty lacunae. Lymphocytes dominated the inflammatory infiltrate, with rarely observed macrophages present in close proximity to the implant site. No giant cells were observed. Immunohistochemistry showed mixed populations of lymphocytes, both CD3 positive (T cells) and CD79a positive (B cells), which in some cases formed lymphoid follicles. Diffuse inflammatory changes were present to a minor extent in the perimysium and surrounding fascia. The inflammation observed in dogs is similar to that observed with gold implants in humans. It is possible that the clinically beneficial effect of gold beads for chronic osteoarthritis depends on sustained localized inflammation with localized release of soluble mediators. The encapsulation of the implant by a paucicellular and poorly vascularized fibrous capsule may help prevent an exaggerated inflammatory reaction by sequestering the gold bead from the surrounding tissue.


Subject(s)
Dog Diseases/pathology , Foreign-Body Reaction/veterinary , Gold/adverse effects , Hip Dysplasia, Canine/pathology , Osteoarthritis, Hip/veterinary , Animals , B-Lymphocytes/metabolism , Biocompatible Materials , Dog Diseases/therapy , Dogs , Double-Blind Method , Euthanasia, Animal , Female , Foreign-Body Reaction/pathology , Gold/administration & dosage , Hip Dysplasia, Canine/therapy , Hip Joint/pathology , Immunohistochemistry/veterinary , Male , Mice , Microspheres , Osteoarthritis, Hip/pathology , Osteoarthritis, Hip/therapy , Pain Measurement/veterinary , Palliative Care/methods , Rabbits , T-Lymphocytes/metabolism , Time Factors
3.
Vet Comp Orthop Traumatol ; 23(4): 250-3, 2010.
Article in English | MEDLINE | ID: mdl-20585717

ABSTRACT

This report describes the Fixin internal fixator system(a), a fracture fixation device characterised by a locking conical coupling between screw heads and titanium alloy inserts that are screwed into a stainless steel plate construct. The mechanical principles, implants, instruments and surgical technique are discussed.


Subject(s)
Bone and Bones/surgery , Dog Diseases/surgery , Fracture Fixation, Internal/instrumentation , Fractures, Bone/veterinary , Internal Fixators/veterinary , Animals , Dogs , Equipment Design , Fractures, Bone/surgery , Prostheses and Implants , Stainless Steel
4.
Med Mycol ; 48(1): 188-96, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19886763

ABSTRACT

Fungi in the genus Penicillium, particularly P. crustosum, produce tremorgenic mycotoxins, as well as suspected tremorgenic compounds. The accidental intoxication of six dogs with such toxins are reported. The clinical signs included vomiting, convulsions, tremors, ataxia, and tachycardia, all of which are indicators of intoxications affecting the nervous system. This symptomatology caused us to think that the dog poisoning was the result of tremorgenic mycotoxins. One dog was euthanized in the acute phase, while three others recovered completely within a few days. However, neurological symptoms were still observed four months after the poisoning of two of the dogs. One of these recovered completely within the next 2-3 months, while the other still suffers from ataxia three years later. Available samples of feed, stomach content and/or tissues from the intoxications were subjected to mycological and chemical analysis. Penitrem A was found in all reported poisonings and roquefortine C in all cases when this toxin was included in the analysis. The producer of these toxins, Penicillium crustosum, was detected in all cases where material suitable for mycological examinations (feed or vomit) was available. To our knowledge, this is the first report documenting the presence of penitrems and roquefortine C in organs from poisoned dogs. Furthermore, the report indicates that the recovery period after severe poisonings with P. crustosum may be protracted.


Subject(s)
Dog Diseases/pathology , Mycotoxins/toxicity , Penicillium/enzymology , Poisoning/veterinary , Tremor/chemically induced , Animals , Dog Diseases/microbiology , Dogs , Female , Food Analysis , Food Microbiology , Gastrointestinal Contents/chemistry , Gastrointestinal Contents/microbiology , Heterocyclic Compounds, 4 or More Rings/isolation & purification , Indoles/isolation & purification , Male , Mycotoxins/isolation & purification , Penicillium/isolation & purification , Piperazines/isolation & purification , Poisoning/microbiology , Poisoning/pathology
6.
J Small Anim Pract ; 48(12): 678-82, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17725588

ABSTRACT

OBJECTIVES: To characterise distal tibial valgus deformities in dogs through physical examination and radiographic evaluation. METHODS: In a clinical study of 16 client-owned dogs, twelve unilateral and four bilateral distal tibial valgus deformities were evaluated using palpation and radiographs. The origin and amplitude of angulation, rotation and length deficits if present were measured. Radiographically, fibular length and position in relation to the tibia was compared in affected and clinically normal limbs. The dimensions of the fibular physes were also compared between clinically normal and affected limbs. RESULTS: Rottweilers and Shetland sheepdogs were overrepresented. Valgus deformities ranged from 16 degrees to 48 degrees (median, 32 degrees ) in affected and from 0 degrees to 13 degrees (median, 6 degrees ) in contralateral, clinically normal limbs. Fibular length, fibular position relative to the tibia or physeal dimensions were not statistically different between affected and clinically normal limbs. CONCLUSION AND CLINICAL RELEVANCE: Many distal tibial valgus deformities in dogs are a uniplanar deformity without concurrent craniocaudal or rotational changes or length deficits. A growth cessation in the fibula does not appear to be responsible for the development of the deformity.


Subject(s)
Dog Diseases/surgery , Joint Deformities, Acquired/veterinary , Osteotomy/veterinary , Tibia/surgery , Animals , Dog Diseases/diagnostic imaging , Dog Diseases/epidemiology , Dog Diseases/pathology , Dogs , Female , Joint Deformities, Acquired/surgery , Male , North Carolina/epidemiology , Radiography , Retrospective Studies
7.
Vet Rec ; 158(21): 722-6, 2006 May 27.
Article in English | MEDLINE | ID: mdl-16731702

ABSTRACT

Seventy-eight dogs with pain due to hip dysplasia were studied in a controlled, double-blind clinical trial to evaluate gold bead implantation as a pain-relieving treatment. The dogs were randomly assigned to two groups, 36 in the gold implantation group and 42 in the placebo group. Both groups were treated equally regarding anaesthesia, hair clipping and penetration of the skin with the same type of needle. The gold implantation group had small pieces of 24 carat gold inserted through needles at five different acupuncture points and the placebo group had the skin penetrated at five non-acupuncture points so as to avoid any possible effect of stimulating the acupuncture points. A certified veterinary acupuncturist marked the points, and two surgeons performed the implantations according to a randomisation code made in advance. After 14 days, three months and six months, the owners assessed the overall effect of the treatments by answering a questionnaire, and the same veterinarian examined each dog and evaluated its degree of lameness by examining videotaped footage of it walking and trotting. The treatment was blinded for both the owners and the veterinarian. There were significantly greater improvements in mobility and greater reductions in the signs of pain in the dogs treated with gold implantation than in the placebo group. The veterinarian's and the owners' assessments corresponded well.


Subject(s)
Hip Dysplasia, Canine/drug therapy , Organogold Compounds/administration & dosage , Pain/veterinary , Acupuncture Points , Animals , Dogs , Double-Blind Method , Hip Dysplasia, Canine/complications , Hip Dysplasia, Canine/physiopathology , Lameness, Animal/diagnosis , Lameness, Animal/etiology , Microspheres , Pain/etiology , Pain Management , Pain Measurement/methods , Pain Measurement/veterinary , Surveys and Questionnaires , Treatment Outcome , Videotape Recording
8.
Am J Transplant ; 5(12): 2982-91, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16303014

ABSTRACT

Bronchiolitis obliterans syndrome (BOS) is the limiting factor to long-term survival after lung transplantation. Previous studies suggested respiratory viral tract infections are associated with the development of BOS. To identify the impact of virus detection in bronchoalveolar lavage (BAL) fluid, we analyzed BAL samples from 87 consecutive lung transplant recipients for human herpesvirus (HHV)-6, Epstein-Barr virus, Herpes simplex virus 1/2, Cytomegalovirus, respiratory syncytical virus and adenovirus by PCR. Acute rejection, BOS and death were recorded for a mean follow-up time of 3.27 +/- 0.47 years. Results of PCR analysis and other potential risk factors were entered into a Cox regression analysis of BOS predictors and death. Only acute rejection was a distinct risk factor for BOS of all stages, death and death from BOS. HHV-6 was detected in 20 patients. Univariate and multivariate analysis revealed that HHV-6 was associated with an increased risk to develop BOS > orb = stage 1 and death, separate from the risk attributable to acute rejection. Identification of HHV-6 DNA in BAL fluid is a potential risk factor for BOS. Our results warrant further studies to elucidate a possible causal link between HHV-6 and BOS.


Subject(s)
Bronchiolitis Obliterans/mortality , Bronchoalveolar Lavage Fluid/virology , Herpesvirus 6, Human , Lung Transplantation/mortality , Roseolovirus Infections/mortality , Adenoviridae Infections/mortality , Adult , Bronchiolitis Obliterans/virology , Cohort Studies , Cytomegalovirus Infections/mortality , DNA, Viral/analysis , Epstein-Barr Virus Infections/mortality , Female , Herpes Simplex/mortality , Herpesvirus 1, Human , Herpesvirus 2, Human , Herpesvirus 6, Human/genetics , Humans , Incidence , Male , Middle Aged , Polymerase Chain Reaction , Postoperative Complications/mortality , Postoperative Complications/virology , Risk Factors
9.
Acta Vet Scand ; 46(1-2): 57-68, 2005.
Article in English | MEDLINE | ID: mdl-16108213

ABSTRACT

UNLABELLED: The purpose of this study was to investigate the need for and choice of stratification factors, and the effects of blinding and placebo in a clinical experiment. Eighty dogs with canine hip dysplasia (CHD) were included in a randomized, placebo-controlled and double blind clinical trial with stratified parallel group design, in which body weight and degree of CHD were used as stratification factors. Thirty-eight dogs were allocated to gold bead implantation and 42 to placebo. After six months, 33 of the 42 placebo-treated dogs received gold bead implantation in an open study lasting a further 18 months. The main outcome variable in the study was change in pain signs of CHD as assessed by the owner. No significant difference in the main outcome variable, regardless of the treatment given, could be detected in the two chosen stratification factors. The only factor to influence the main outcome variable significantly was age. The blinding procedure used in the study, in which 60% of the owners correctly guessed the treatment given, was found sufficient. Of those who guessed the treatment erroneously, 88% believed the treatment given was gold bead implantation. The treatment efficacy after six months in the blinded treatment group was found to be significantly larger compared to the efficacy obtained in the open study. A significant placebo effect was therefore detected. CONCLUSION AND CLINICAL RELEVANCE: The age of the dogs influenced the outcome of the CHD treatment, and is recommended as a stratification factor. A significant placebo effect has to be expected and an optimal blinding procedure is necessary in similar clinical studies.


Subject(s)
Antirheumatic Agents/therapeutic use , Hip Dysplasia, Canine/therapy , Age Factors , Animals , Body Weight , Dogs , Female , Hip Dysplasia, Canine/classification , Male , Organogold Compounds , Placebo Effect , Prostheses and Implants , Severity of Illness Index
10.
Tissue Antigens ; 65(3): 295-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15730528

ABSTRACT

The frequency of human platelet antigen-1 (HPA-1) to HPA-11w (excluding HPA-8w) and HPA-15 systems was studied in four sub-Saharan populations: Beninese, Congolese (Democratic Republic of Congo Kinshasa), Cameroonians, and Aka pygmies (Central African Republic). No report of HPA prevalence has previously been published concerning these populations which are characterized by the highest HPA-2b gene frequencies of any reported to date (Aka 0.393, Benin 0.292, Cameroon 0.237, and Congo 0.224) and at lesser degree HPA-5b (Aka 0.405, Congo 0.268, Cameroon 0.254, and Benin 0.182). This study is of great importance (i) particularly in the context of the diversity caused by the population migrations, we may observe today in our hospitals (ii) to confirm that the Pygmy population with distinctive frequencies (absence of the HPA-1b, HPA-2b, and HPA-5b highest frequencies) is an isolated population.


Subject(s)
Antigens, Human Platelet/genetics , Black People/genetics , Polymorphism, Genetic , Africa South of the Sahara/ethnology , Gene Frequency , Humans
11.
Vet Comp Orthop Traumatol ; 18(2): 73-6, 2005.
Article in English | MEDLINE | ID: mdl-16594201

ABSTRACT

The isometry of the bipartite medial collateral ligament of the tarsus and two methods of stabilization by prosthetic ligament were assessed by measuring the change in distance between the origin and the insertion through full range of joint motion of the ligament and prosthetic ligaments. The single suture technique was isometric when the distal site was located at the centre of the trochlea of the talus. This site can only be used when the medial malleolus, which overlies the talus, is missing or removed. Whilst some length changes occur with hock motion, the double suture technique may be advocated in instances where the medial malleolus is present.


Subject(s)
Collateral Ligaments/surgery , Dogs/surgery , Range of Motion, Articular , Suture Techniques/veterinary , Tarsal Joints/surgery , Tibia/surgery , Animals , Biomechanical Phenomena , Cadaver , Hindlimb
13.
Hautarzt ; 52(10 Pt 2): 950-1, 2001 Oct.
Article in German | MEDLINE | ID: mdl-11715391

ABSTRACT

A 10-year-old boy in Uganda developed primary anetoderma (Schwenninger-Buzzi). It is important not to confuse anetoderma with BL leprosy in spite of some superficial resemblance of the two diseases. Primary anetoderma is probably extremely rare in patients with dark skin although this may partly be due to a lack of dermatologists in Africa who could diagnose the disease.


Subject(s)
Skin Diseases , Atrophy , Black People , Child , Diagnosis, Differential , Humans , Male , Skin/pathology , Skin Diseases/diagnosis , Syndrome , Uganda
14.
Leuk Lymphoma ; 40(3-4): 345-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11426556

ABSTRACT

Ineffective hematopoiesis leading to profound cytopenias represents a major clinical problem in the management of patients with myelodysplastic syndrome (MDS). The aminothiol amifostine has shown to promote multilineage hematopoiesis both in vivo and in vitro in patients with MDS. We have treated 10 patients with 250 mg/m2 amifostine thrice weekly in combination with erythropoietin for 4 consecutive weeks followed by 2 weeks observation. Responding patients received the same 6 week schedule, while nonresponder received G-CSF in addition to erythropoietin and amifostine during the second treatment course. All patients experienced single or multilineage hematologic improvement, but only 2 reached transfusion independency. Moreover, response was durable only in a minority of patients and thus additional studies are warranted to further define the potential interaction of amifostine and growth factors.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Hematopoiesis/drug effects , Myelodysplastic Syndromes/drug therapy , Aged , Aged, 80 and over , Amifostine/administration & dosage , Amifostine/pharmacology , Amifostine/toxicity , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Antineoplastic Combined Chemotherapy Protocols/toxicity , Blood Cell Count , Cell Lineage , Erythropoietin/administration & dosage , Erythropoietin/pharmacology , Erythropoietin/toxicity , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte Colony-Stimulating Factor/pharmacology , Granulocyte Colony-Stimulating Factor/toxicity , Humans , Middle Aged , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/complications , Treatment Outcome
15.
Vaccine ; 19(17-19): 2756-61, 2001 Mar 21.
Article in English | MEDLINE | ID: mdl-11257420

ABSTRACT

Our current knowledge allows the generation of transgenic plants that efficiently produce heterologous proteins from plant, bacterial, fungal or animal origin. Among all types of recombinant proteins, antibodies are particularly attractive because of their ability to specifically recognize and bind virtually any type of antigen. Plants show several advantages as a large-scale antibody production system: they can be grown easily and inexpensively in large quantities that can be harvested, stored and processed by using existing infrastructures. Isolation and purification of plant-made antibodies, if necessary, allow fundamental, industrial, and therapeutical applications. In the past, we and others have successfully generated antibody-producing plants. The maximal accumulation levels of antibodies and antibody fragments that we observed are 1-5% of the extracted proteins. Currently, several biotechnological companies grow field crops to produce antibodies for ex planta applications on an industrial scale.


Subject(s)
Immunoglobulin Fragments/biosynthesis , Plants, Genetically Modified/genetics , Plants, Genetically Modified/immunology , Animals , Bioreactors , Biotechnology , Gene Expression , Humans , Immunoglobulin Fragments/genetics , Immunoglobulin Fragments/isolation & purification , Immunoglobulins/biosynthesis , Immunoglobulins/genetics , Immunoglobulins/isolation & purification
17.
Tissue Antigens ; 58(4): 211-22, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11782272

ABSTRACT

HLA-DRB1, -DQB1 and -DPB1 polymorphisms were investigated in two African populations, the Basse Lobaye Aka Pygmies of the Central African Republic, and a Bantu-speaking group from the Democratic Republic of Congo Kinshasa. Allelic and haplotypic frequency distributions reveal marked differences between the two populations in spite of their geographical proximity: the Aka exhibit high frequencies for several alleles, especially at the DPB1 locus (0.695 for DPB1*0402), probably due to rapid genetic drift, while the Bantu distributions are more even. Genetic distances computed from DRB1 allelic frequencies among 21 populations from North and sub-Saharan Africa were applied to a multidimensional scaling analysis. African populations genetic structure is significantly shaped by linguistic differentiation, as confirmed by an analysis of molecular variance. However, selective neutrality tests indicate that many African populations exhibit an excess of heterozygotes for DRB1, which is likely to explain the genetic similarity observed between some North African and Bantu populations. Overall, this study shows that natural selection must be taken into account when interpreting the patterns of HLA diversity, but that this effect is probably minor in relation to the stochastic events of human population differentiations.


Subject(s)
Genes, MHC Class II , HLA-DR Antigens/genetics , Polymorphism, Genetic , Adult , Aged , Central African Republic/ethnology , Democratic Republic of the Congo/ethnology , Female , Gene Frequency , HLA-DP Antigens/genetics , HLA-DP beta-Chains , HLA-DQ Antigens/genetics , HLA-DQ alpha-Chains , HLA-DQ beta-Chains , HLA-DRB1 Chains , Haplotypes , Humans , Linkage Disequilibrium , Male , Middle Aged
18.
Eur J Biochem ; 267(23): 6775-83, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11082187

ABSTRACT

In order to obtain recombinant antibody fragments that bind the cell-cycle protein CDC2a from Arabidopsis thaliana (CDC2aAt), two phage display libraries of single-chain variable (scFv) fragments were constructed. One library was derived from mice immunized with recombinant CDC2aAt N-terminally fused to a His6-tag (His-CDC2aAt) and the other was made out of an anti-PSTAIRE hybridoma cell line. Six specific His-CDC2aAt-binding phage clones (3D1, 3D2, 3D10, 3D25, 4D21 and 4D47) were isolated by panning. The isolated monoclonal phage clones, as well as the soluble scFv fragments produced in the periplasm of Escherichia coli, bind His-CDC2aAt in ELISA and on Western blots. Moreover, four clones (3D1, 3D2, 3D10 and 4D21) detect specifically CDC2aAt from Arabidopsis cell suspensions on Western blots. Clone 4D21 binds the PSTAIRE epitope, whereas the 3D1, 3D2 and 3D10 clones bind, as yet unidentified, epitopes of CDC2aAt. Furthermore, the accumulation and antigen-binding activity of these scFv fragments in a reducing environment were assessed. No interaction could be shown between the scFv fragments and CDC2aAt in a yeast two-hybrid assay. However, after transient expression of the scFv fragments in the cytosol of tobacco leaves, three of six scFv fragments (3D1, 3D2 and 3D10) accumulated in the plant cytosol and ELISA results indicate that these scFv fragments retained antigen-binding activity.


Subject(s)
Antibodies, Monoclonal/chemistry , Arabidopsis Proteins , Arabidopsis/chemistry , Arabidopsis/immunology , CDC2 Protein Kinase/immunology , Cyclin-Dependent Kinases/chemistry , Cyclin-Dependent Kinases/immunology , Immunoglobulin Fragments/chemistry , Immunoglobulin Fragments/isolation & purification , Amino Acid Sequence , Animals , Blotting, Western , CDC2 Protein Kinase/chemistry , Codon, Terminator , Enzyme-Linked Immunosorbent Assay , Epitopes , Escherichia coli/metabolism , Hybridomas , Mice , Molecular Sequence Data , Peptide Library , Peptides/chemistry , Protein Binding , Recombinant Proteins/chemistry , Sequence Homology, Amino Acid , Tumor Cells, Cultured , Two-Hybrid System Techniques
19.
Plant Mol Biol ; 43(4): 419-28, 2000 Jul.
Article in English | MEDLINE | ID: mdl-11052194

ABSTRACT

Immunomodulation is a molecular technique that allows the interference with cellular metabolism or pathogen infectivity by the ectopic expression of genes encoding antibodies or antibody fragments. In recent years, several reports have proven the value of this tool in plant research for modulation of phytohormone activity and for blocking plant-pathogen infection. Efficient application of the plantibody approach requires different levels of investigation. First of all, methods have to be available to clone efficiently the genes coding for antibodies or antibody fragments that bind the target antigen. Secondly, conditions to obtain high accumulation of antigen-binding antibodies and antibody fragments in plants are being investigated and optimized. Thirdly, different strategies are being evaluated to interfere with the function of the target molecule, thus enabling immunomodulation of metabolism or pathogen infectivity. In the near future, optimized antibody gene isolation and expression, especially in reducing subcellular environments, such as the cytosol and nucleus, should turn immunomodulation into a powerful and attractive tool for gene inactivation, complementary to the classical antisense and co-suppression approaches.


Subject(s)
Plants/genetics , Plants/immunology , Antibodies/genetics , Gene Expression Regulation, Plant , Plant Diseases/genetics , Plants/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/immunology , Plants, Genetically Modified/metabolism
20.
Plant Mol Biol ; 43(2-3): 347-59, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10999415

ABSTRACT

Plants are particularly attractive as large-scale production systems for proteins intended for therapeutical or industrial applications: they can be grown easily and inexpensively in large quantities that can be harvested and processed with the available agronomic infrastructures. The effective use of plants as bioreactors depends on the possibility of obtaining high protein accumulation levels that are stable during the life cycle of the transgenic plant and in subsequent generations. Silencing of the introduced transgenes has frequently been observed in plants, constituting a major commercial risk and hampering the general economic exploitation of plants as protein factories. Until now, the most efficient strategy to avoid transgene silencing involves careful design of the transgene construct and thorough analysis of transformants at the molecular level. Here, we focus on different aspects of the generation of transgenic plants intended for protein production and on their influence on the stability of heterologous gene expression.


Subject(s)
Plant Proteins/biosynthesis , Plants/genetics , Bioreactors , Gene Silencing , Plants/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Transgenes/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...